Skip to content

Attention to breath sensations does not engage endogenous opioids to reduce pain.

Rebecca E Wells, Jason Collier, Grace Posey, Afrayem Morgan, Timothy Auman, Brian Strittmatter, Rossana Magalhaes, Adrienne L Adler-Neal, John G. Mchaffie, Fadel Zeidan

Pain March 9, 2020 DOI: 10.1097/j.pain.0000000000001865 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Double-blind, placebo-controlled crossover study Peer reviewed
Sample size 59
Population Adults experiencing noxious heat pain
Interventions Mindfulness meditation Sham-mindfulness meditation Slow-paced breathing Naloxone
Dose 0.15 mg/kg bolus + 0.1 mg/kg/hour maintenance infusion
Topics Meditation
Keywords Humans Naloxone Analgesics, opioid Cross-over studies Adult Pain management
Key points Mindfulness meditation and slow-paced breathing reduced pain (unpleasantness and/or intensity) in ways that were insensitive to the opioid antagonist naloxone, whereas sham mindfulness reduced unpleasantness only during saline and this effect was reversed by naloxone. The authors conclude that slow breathing combined with attention to breath reduces pain independent of endogenous opioids.

Abstract

The endogenous opioidergic system is critically involved in the cognitive modulation of pain. Slow-breathing-based techniques are widely used nonpharmacological approaches to reduce pain. Yet, the active mechanisms of actions supporting these practices are poorly characterized. Growing evidence suggest that mindfulness-meditation, a slow-breathing technique practiced by nonreactively attending to breathing sensations, engages multiple unique neural mechanisms that bypass opioidergically mediated descending pathways to reduce pain. However, it is unknown whether endogenous opioids contribute to pain reductions produced by slow breathing. The present double-blind, placebo-controlled crossover study examined behavioral pain responses during mindfulness-meditation (n = 19), sham-mindfulness meditation (n = 20), and slow-paced breathing (n = 20) in response to noxious heat (49°C) and intravenous administration (0.15 mg/kg bolus + 0.1 mg/kg/hour maintenance infusion) of the opioid antagonist, naloxone, and placebo saline. Mindfulness significantly reduced pain unpleasantness ratings across both infusion sessions when compared to rest, but not pain intensity. Slow-paced breathing significantly reduced pain intensity and unpleasantness ratings during naloxone but not saline infusion. Pain reductions produced by mindfulness-meditation and slow-paced breathing were insensitive to naloxone when compared to saline administration. By contrast, sham-mindfulness meditation produced pain unpleasantness reductions during saline infusion but this effect was reversed by opioidergic antagonism. Sham-mindfulness did not lower pain intensity ratings. Self-reported "focusing on the breath" was identified as the operational feature particularly unique to the mindfulness-meditation and slow paced-breathing, but not sham-mindfulness meditation. Across all individuals, attending to the breath was associated with naloxone insensitive pain-relief. These findings provide evidence that slow breathing combined with attention to breath reduces pain independent of endogenous opioids.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Cited by 16

and 11 more in the library

Cites 19

and 14 more in the library

Explore topics